Sabra Health Care REIT, Inc. provided earnings guidance for the year 2024. For the period, the company expects Net Income attributable to common stockholders, per diluted common share of $0.53 to $0.57.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 USD | +2.12% | +2.05% | -2.31% |
Feb. 28 | Transcript : Sabra Health Care REIT, Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 28 | Sabra Health Care REIT Q4 Adjusted FFO, Revenue Decline; Issues 2024 Guidance | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.31% | 3.23B | |
+4.62% | 55.76B | |
-11.72% | 17.72B | |
-5.05% | 13.23B | |
+1.40% | 7.68B | |
-17.93% | 5.39B | |
+8.62% | 3.28B | |
-5.42% | 3.06B | |
-8.15% | 2.73B | |
+12.61% | 2.73B |
- Stock Market
- Equities
- SBRA Stock
- News Sabra Health Care REIT, Inc.
- Sabra Health Care REIT, Inc. Provides Earnings Guidance for the Year 2024